USEUROPEAFRICAASIA 中文双语Français
China
Home / China / Cover Story

Taking a lead in fight against malaria

By Shan Juan in Beijing and Li Lianxing in Nairobi, Kenya | China Daily | Updated: 2013-02-20 09:22

Taking a lead in fight against malaria

A child (front) with malaria waits for treatment at a refugee camp in Abidjan, a port city in Cote d'Ivoire. One million people are killed by the disease in Africa every year. [Ding Haitao / Xinhua]

Cheap, but effective

Purity Muya, a 34-year-old Kenyan, said her son was saved by Chinese anti-malaria medicines.

"It only took three days to cure my son, who contracted malaria last summer," she said. "The total expense was 100 Kenyan shillings ($1.15) and was quite acceptable."

Fayyaz Mohammedtaqi, chief of pharmacy and outpatient services at the Aga Khan Hospital in the Tanzanian capital, Dar es Salaam, told Xinhua News Agency the hospital uses two types of Chinese-made malaria treatments, Duo-Cotecxin and Artesun.

"They are as effective as those made by Western companies, such as Coartem by Novartis, which, however, is far more expensive," he said.

Stephen Kyebambe, a physician at China-Naguru Friendship Hospital in Kampala, Uganda, said an increasing number of patients in Africa choose cheap, but effective, Chinese drugs in preference to Western-made medicines.

Meanwhile, a number of industry experts dismissed the media reports.

Xia Zhigui, deputy director of the malaria department of the National Institute of Parasitic Diseases, said he had never heard of counterfeit Chinese malaria treatments in Africa.

Xia traveled to Cameroon and the Democratic Republic of Congo in 2009 to set up anti-malaria centers under a program announced in 2006 that would see China help to establish 30 malaria prevention and treatment centers in Africa.

The centers benefit patients in Africa, improve the continent's malaria-intervention capacity and promote the transfer of knowledge between clinics and research institutes.

"Chinese-made anti-malaria drugs are popular with Africans and they are generally very effective as well, so I don't understand why some parts of the media printed these stories," said Xia.

"I think the accusations were just a campaign story, which I feel should not be taken too seriously," said Asuman Lukwago, permanent secretary of the Ugandan Ministry of Health.

Kate Kikule, chief drug inspector at Uganda's National Drug Authority, said so far no survey has been conducted to establish that the counterfeits originated in China.

Yu Zhemin, chairman of Guilin Pharmaceutical Co, said his company has not detected any counterfeits of the anti-malaria drugs it markets in Africa.

According to Yu, 80 percent of Guilin's products enter Africa through international organization procurement, and the remaining 20 percent is moved through partnerships with local sales networks.

"The medicines have to pass tests conducted by the local drug authorities and must be registered before hitting the market," he said.

But he conceded that sales channels in Africa are not well regulated. "Some qualified grocery stores also sell anti-malarials," he said.

In the meantime, African governments are taking steps to control counterfeit medicines. The regulatory bodies in Uganda, Kenya, Nigeria and a number of other countries are making contracts with companies to supply the drugs or sending their own employees to India and China to assess the efficiency of the quality control process.

Yu said his company's production facilities in China have been visited and assessed by inspectors from countries such as Sudan, Kenya, Uganda and Tanzania.

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US